Overview

Treatment Effect According to Timing of Administration of DWP14012 40 mg

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to establish noninferiority of efficacy of DWP14012 (40 mg once daily) based on Timing of Administration.
Phase:
N/A
Details
Lead Sponsor:
Konkuk University Medical Center
Collaborator:
Daewoong Pharmaceutical Co. LTD.